United States Muscle Spasticity Market is expected to reach US$ 7.7 Billion by 2030 | Top key players - Ipsen Pharma, Allergan, Novartis AG.

Market Size and Forecast:

The Global Muscle Spasticity Market Size reached US$ 4.2 billion in 2022 and is expected to reach US$ 7.7 billion by 2030, growing with a CAGR of 8.1% during the forecast period 2024-2031.

The Muscle Spasticity Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/muscle-spasticity-market?sz

The Muscle Spasticity Market refers to the global industry focused on developing, manufacturing, and commercializing therapies, medications, and medical devices aimed at managing muscle stiffness, involuntary contractions, and related movement disorders. This market encompasses pharmacological treatments, botulinum toxin injections, and supportive care devices, catering to patients with conditions like cerebral palsy, multiple sclerosis, stroke, and spinal cord injuries, driven by rising prevalence and awareness.

Industry Recent Developments:

United States:

✅ July 2025: Increased investment and projected growth in the spasticity treatment market driven by innovation in neuromodulators and rehabilitation technologies, indicating expanding R&D and evolving treatment modalities.

✅ August 2025: The FDA granted XEOMIN a pediatric indication for upper-limb spasticity (excluding cerebral palsy), expanding access to children aged 2+ with neurological spasticity and enhancing long-term management options.

✅ August 2025: Ongoing market expansion due to the adoption of botulinum toxin and other oral medications for reducing nerve signals causing muscle contractions, along with rising use of electrical stimulation techniques such as FES and TENS.

Japan:

✅ Rising prevalence of muscle spasticity-related neurological conditions like multiple sclerosis and cerebral palsy is driving the growth of the intrathecal pumps market for spasticity treatment with a focus on baclofen drug delivery.

✅ Baclofen remains the dominant drug for muscle spasticity treatment in Japan due to its efficacy in reducing muscle spasms, while morphine use is also growing for pain management related to spasticity.

✅ Expansion of telehealth services and launch of new medical devices aimed at improving patient compliance and spasticity treatment outcomes in Japan, coupled with regulatory oversight by PMDA ensuring high safety and efficacy standards.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/muscle-spasticity-market?sz

Major Key Players:

Ipsen Pharma
Allergan
Acorda Therapeutics, Inc.
Merz Pharma
Novartis AG
Beximco Pharmaceuticals Ltd.
Zydus Cadila
Others.

Key Growth Drivers:

Increasing prevalence of neurological and musculoskeletal disorders such as multiple sclerosis, strokes, spinal cord injuries, and cerebral palsy, which lead to muscle spasticity symptoms like involuntary muscle contractions and stiffness.

Advances in research and development, including the expansion of clinical indications, development of targeted drug delivery systems, and introduction of innovative treatments such as oral suspensions, botulinum toxin injections, and electrical stimulation techniques.

Favorable regulatory approvals, reimbursement policies, and a growing emphasis on patient-centric care with multimodal treatment approaches that improve quality of life and functional abilities of patients affected by muscle spasticity.

Segments Covered in the Muscle Spasticity Market:

By Drug Type: Baclofen, Botulinum Toxin, Diazepam, Dantrolene Sodium, Others.

By Route of Administration: Oral, Intramuscular, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=muscle-spasticity-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Muscle Spasticity market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Muscle Spasticity Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Muscle Spasticity market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Muscle Spasticity Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Muscle Spasticity Market in 2025?
◆ What is the projected growth rate of the Muscle Spasticity Market through 2033?
◆ Who are the key players in the Muscle Spasticity Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.